March 20, 2024 · Form 4 insider transaction
Pizzuti Dana sold 4,375 shares of Crinetics Pharmaceuticals, Inc. at $45.89 per share, a transaction worth $200.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.